Ken Redekop

Ken Redekop, PhD, is an Associate Professor at the Institute for Medical Technology Assessment within the Erasmus School of Health Policy & Management at Erasmus Universiteit Rotterdam, Netherlands. He specializes in clinical epidemiology, with over 20 years of experience in observational research, clinical trials, and medical technology assessment. His work focuses on cost-effectiveness analyses of medical devices, diagnostics, and therapies, particularly in diabetes, cardiovascular disease, and cancer. He has authored over 100 publications and contributed to national and international healthcare decision-making frameworks.

Research Interests:

• Cost-effectiveness analyses of medical technologies and therapies
• Economic evaluations of diagnostics (e.g., NICE Diagnostics Assessment Programme)
• Modeling and evidence synthesis in healthcare decision-making
• Remote monitoring solutions in chronic disease management
• Personalized nutrition interventions

Awards:

• Recipient of the 2016 prize for data-mining in HER2-positive breast cancer cost analysis

Advising & Grants: Supervised 13 research works and contributed to large-scale studies like the REMOTE-CIED economic evaluation. Collaborates internationally on projects involving health technology assessment for radiology AI and Parkinson's disease management.

Labs/Teams: Active in the Health Technology Assessment (HTA) research group, contributing to multidisciplinary teams evaluating emerging medical technologies.